Connection

Ali Rizvi to Dipeptidyl Peptidase 4

Back to Details
This is a "connection" page, showing publications Ali Rizvi has written about Dipeptidyl Peptidase 4.
Ali Rizvi
Connection Strength
0.198
Dipeptidyl Peptidase 4
  1. Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors. Metabolism. 2020 10; 111:154343.
    View in: PubMed
    Score: 0.177
  2. Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors. Expert Opin Investig Drugs. 2009 Oct; 18(10):1495-503.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.